Abstract:Xanthine oxidase inhibitors (XOIs) have been widely studied due to the promising potential as safe and effective therapeutics in hyperuricemia and gout. Currently, available XOI molecules have been developed from different experiments but they are with the wide structure diversity and significant varying bioactivities. So it is of great practical significance to present a consensual QSAR model for effective bioactivity prediction of XOIs based on a systematic compiling of these XOIs across different experiments. In this work, 249 XOIs belonging to 16 scaffolds were collected and were integrated into a consensual dataset by introducing the concept of IC 50 values relative to allopurinol (RIC 50 ). Here, extended connectivity fingerprints (ECFPs) were employed to represent XOI molecules. By performing effective feature selection by machine-learning method, 54 crucial fingerprints were indicated to be valuable for predicting the inhibitory potency (IP) of XOIs. The optimal predictor yields the promising performance by different cross-validation tests. Besides, an external validation of 43 XOIs and a case study on febuxostat also provide satisfactory results, indicating the powerful generalization of our predictor. Here, the predictor was interpreted by shapely additive explanation (SHAP) method which revealed several important substructures by mapping the featured fingerprints to molecular structures. Then, 15 new molecules were designed and predicted by our predictor to show superior IP than febuxostat. Finally, molecular docking simulation was performed to gain a deep insight into molecular binding mode with xanthine oxidase (XO) enzyme, showing that molecules with selenazole moiety, cyano group and isopropyl group tended to yield higher IP. The absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction results further enhanced the potential of these novel XOIs as drug candidates. Overall, this work presents a QSAR model for accurate prediction of IP of XOIs, and is expected to provide new insights for further structure-guided design of novel XOIs.

Xanthine Oxidase Targeted Model Setup and Its Application for Antihyperuricemic Compounds Prediction by in Silico Methods

A Consensual Machine-Learning-assisted QSAR Model for Effective Bioactivity Prediction of Xanthine Oxidase Inhibitors Using Molecular Fingerprints

Various machine learning approaches coupled with molecule simulation in the screening of natural compounds with xanthine oxidase inhibitory activity

Exploration of Novel Non-Purine Xanthine Oxidase Inhibitors Based on Oxadiazolones by an Integrated Simulation Study

Study on the Activity of Non-Purine Xanthine Oxidase Inhibitor by 3D-Qsar Modeling and Molecular Docking

Xanthine oxidase inhibitors: Virtual screening and mechanism of inhibition studies

Quantitative Prediction of Thiazole Derivatives as Potent Xanthine Oxidase Inhibitors

A Modified Xanthine Oxidase Cell Model for Screening of Antihyperuricemic Functional Compounds

Identification of Natural Xanthine Oxidase Inhibitors: Virtual Screening, Anti-Xanthine Oxidase Activity, and Interaction Mechanism.

Virtual-screening of Xanthine Oxidase Inhibitory Peptides: Inhibition Mechanisms and Prediction of Activity Using Machine-Learning

In Silico Study of Febuxostat Analogs As Inhibitors of Xanthine Oxidoreductase: A Combined 3D-QSAR and Molecular Docking Study

Molecular Modelling Studies of 3,5-Dipyridyl-1,2,4-triazole Derivatives As Xanthine Oxidoreductase Inhibitors Using 3D-Qsar, Topomer Comfa, Molecular Docking and Molecular Dynamic Simulations

Novel Xanthine Oxidase-Based Cell Model Using HK-2 Cell for Screening Antihyperuricemic Functional Compounds.

Virtual Screening and Multi-targets Investigation of Novel Diazine Derivatives as Potential Xanthine Oxidase Inhibitors Based on QSAR, Molecular Docking, ADMET Properties, Dynamics Simulation and Network Pharmacology

Using deep learning and molecular dynamics simulations to unravel the regulation mechanism of peptides as noncompetitive inhibitor of xanthine oxidase

Molecular Dockings and Molecular Dynamics Simulations Reveal the Potency of Different Inhibitors Against Xanthine Oxidase

Screening and Evaluation of Flavonoids As Xanthine Oxidase Inhibitors for Reducing Uric Acid Through Combined Cell Biology and Molecular Simulation

Identification of novel dual inhibitors targeting XOR and URAT1 via multiple virtual screening methods

In Vitro and in Silico Xanthine Oxidase Inhibitory Activity of Selected Phytochemicals Widely Present in Various Edible Plants.

A Strategy for Inhibitors Screening of Xanthine Oxidase Based on Colorimetric Sensor Combined with Affinity Chromatography Technology

Identification of Anastatica hierochuntica L. Methanolic-Leaf-Extract-Derived Metabolites Exhibiting Xanthine Oxidase Inhibitory Activities: In Vitro and In Silico Approaches